<DOC>
	<DOC>NCT02073734</DOC>
	<brief_summary>The investigators hypothesize that preoperative administration of 8 mg IV dexamethasone will benefit patients' perceived quality of recovery after surgery.</brief_summary>
	<brief_title>Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP</brief_title>
	<detailed_description>This is a randomized controlled trial involving single administration of 8 mg Dexamethasone per IV preoperatively among women undergoing vaginal reconstructive surgery for pelvic organ prolapse.</detailed_description>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Women aged 1881 years old who are scheduled to undergo a major vaginal reconstructive surgery, including hysterectomy with or without hysterectomy Daily use of steroids or antiemetic agents such as Zofran, Reglan, Compazine and Phenargan within one month of surgery Regional anesthesia for surgical procedure Chronic pain requiring opioid treatment daily History of allergy to the study medication Severe renal and liver disease Pregnancy Non English speaking Psychiatric disorder that will preclude completion of questionnaires Minor surgery that does not involve overnight admission Surgery that does not involve hysterectomy or vaginal intraperitoneal apical suspension Hypersensitivity reaction to steroids Evidence of systemic fungal infection Evidence of any systemic infection Uncontrolled diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>pelvic organ prolapse surgery</keyword>
	<keyword>dexamethasone</keyword>
	<keyword>postoperative nausea and vomiting</keyword>
	<keyword>peroperative administration</keyword>
</DOC>